COVID-19 in Patients with Myasthenia Gravis
To better understand the effect of a SARS-CoV-2 infection in patients living with Myasthenia Gravis, researchers analyzed 83 Myasthenia Gravis patients who tested positive for COVID-19.
Read More »
Infections
COVID-19 in Patients with Behçet’s disease
Behçet’s disease patients are usually on long-term therapy with colchicine, TNF inhibitors, or glucocorticoids; a recent study aimed to understand the prevalence of COVID-19-related clinical outcomes in Behçet’s disease patients treated with these therapies.
Read More »SARS-CoV-2 Vaccination in Patients with Primary and Secondary Immunodeficiency
A recent study investigated COVID-19 outcomes in patients with primary and secondary immunodeficiency, comparing hospitalization rates and mortality between both vaccinated and unvaccinated patients.
Read More »Treating COVID-19 with Anti-inflammatory Medications
Authors of a recent study looked into the effects of NSAIDs and corticosteroids on inflammation from SARS-CoV-2 infection, as well as their ability to reduce disease progression, including hospitalization.
Read More »